Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Piper Sandler Maintains Neutral on Zynex, Raises Price Target to $10

Piper Sandler Maintains Neutral on Zynex, Raises Price Target to $10

Piper Sandler analyst Adam Maeder maintains Zynex (NASDAQ:ZYXI) with a Neutral and raises the price target from $7 to $10.

byBenzinga Newsdesk

October 28, 2022

1 minute read

Piper Sandler analyst Adam Maeder maintains Zynex (NASDAQ:ZYXI) with a Neutral and raises the price target from $7 to $10.

Analyst Ratings

Roth MKM Maintains Buy Rating for Clearfield: Here’s What You Need To Know

By Benzinga Insights

January 29, 1:00 PM

Roth MKM has decided to maintain its Buy rating of Clearfield (NASDAQ:CLFD) and lower its price target from…

CLFD

Why Fabrinet’s New AI Customer Could Bring in Over $100M Business: An Analyst’s Perspective

By Vandana Singh

June 12, 2:39 PM

Needham increased its price target on Fabrinet (NYSE: FN) from $120 to $150 with a Buy rating</

Reported Earlier, Emergent BioSolutions Announces Preliminary 2022 Financial Results; Sees FY22 Revenue Of $1.1B-$1.12B Vs Prior Guidance Of $1.05B-$1.1B

By Benzinga Newsdesk

January 26, 10:26 AM

PRELIMINARY 2022 FINANCIAL RESULTS (Unaudited) The company is providing the following selected preliminary, unaudited financial results for full-year 2022.

EBS

IonQ Q3 Earnings: Revenue Up 122%, Bookings Growth, Raised Full-Year Outlook And More

By Adam Eckert

November 8, 5:42 PM

IonQ Inc (NYSE: IONQ) reported third-quarter financial results after the bell on Wednesday.

IONQ

Piper Sandler Maintains Neutral on Zynex, Raises Price Target to $10

Related Posts

Roth MKM Maintains Buy Rating for Clearfield: Here’s What You Need To Know

Why Fabrinet’s New AI Customer Could Bring in Over $100M Business: An Analyst’s Perspective

Reported Earlier, Emergent BioSolutions Announces Preliminary 2022 Financial Results; Sees FY22 Revenue Of $1.1B-$1.12B Vs Prior Guidance Of $1.05B-$1.1B

IonQ Q3 Earnings: Revenue Up 122%, Bookings Growth, Raised Full-Year Outlook And More